E. Lindell et al., TACHYKININ-INDUCED NASAL FLUID SECRETION AND PLASMA EXUDATION IN THE RAT - EFFECTS OF PEPTIDASE INHIBITION, Neuropeptides, 28(5), 1995, pp. 309-315
Substance P (SP) evokes fluid secretion and plasma extravasation when
applied to the nasal mucosa of rats. SP and another tachykinin, neurok
inin A (NKA), are degraded in vitro by neutral endopeptidase (NEP) and
angiotensin-1-converting enzyme (ACE). In this study, NKA or SP were
applied locally to the nasal mucosa of rats. Subsequent fluid secretio
n was measured by a filter paper technique. Plasma exudation was deriv
ed as the recovery of intravenous (i.v.) administered I-125-albumin fr
om the fluid-containing filter papers. In order to inhibit enzymatic d
egradation of the tachykinins by NEP and ACE, the rats were treated wi
th i.v. administered phosphoramidon or captopril respectively or their
combination. SP evoked fluid secretion that was augmented by phosphor
amidon and further enhanced by adding captopril. NKA evoked nasal flui
d secretion less effectively than SP and the effect was unaffected by
peptidase inhibition. SP, but not NKA, evoked increased plasma exudati
on but only after pre-treatment with phosphoramidon.